The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With Ustekinumab
Abstract
BACKGROUND: Interleukin (IL)-23 is involved in the pathogenesis of the chronic inflammatory Crohn disease. Pyoderma gangrenosum (PG) is often associated with and can even be the first manifestation of this disease and has abundant neutrophilic infiltration. Because IL-23 plays a critical role in driving inflammation associated with IL-17 production and especially neutrophil recruitment, we suspect that PG might be driven by a pathogenetic mechanism similar to that of inflammatory bowel diseases or psoriasis. OBSERVATIONS: Tissue sample analysis showed highly elevated expression of IL-23 on both transcriptional and protein level in a recalcitrant PG lesion. On the basis on these data, a treatment targeting the p40 subunit of the heterodimeric IL-23 with the monoclonal antibody ustekinumab was started. Therapy with ustekinumab resulted in a significant decrease of IL-23 expression in PG and healing after 14 weeks of treatment. No relapse occurred in a 6-month follow-up period. CONCLUSIONS: Our data provide evidence of an IL-23-dominated inflammatory infiltrate in PG. This might specify a new concept for PG pathophysiology and suggests a possibility for using ustekinumab as a therapeutic agent in this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cited by
Etiology and Management of Pyoderma Gangrenosum: A Comprehensive Review
Ahronowitz, I., Harp, J., & Shinkai, K. (2012) · American Journal of Clinical Dermatology · doi:10.2165/11595240-000000000-00000 · Cited by 409
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment
Alavi, A., French, L. E., Davis, M. D., Brassard, A., & Kirsner, R. S. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0251-7 · Cited by 321
Maverakis, E., Marzano, A. V., Le, S. T., Callen, J. P., Brüggen, M.-C., Guenova, E., Dissemond, J., Shinkai, K., & Langan, S. M. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0213-x · Cited by 285
Self-citationPathophysiology of pyoderma gangrenosum (PG): An updated review
Braswell, S. F., Kostopoulos, T. C., & Ortega-Loayza, A. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.06.021 · Cited by 271
Off-label dermatologic uses of IL-23 inhibitors
Porter, J., Zimmerman, L., Nickles, M., & Hoyer, S. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2024.2436015 · Cited by 3
Metadata
- Authors
- Guenova, E.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2011-10-01
- Volume
- 147
- Issue
- 10
- Pages
- 1203
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2100169892
- Cited by
- 181
- References
- 1
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With Ustekinumab. https://app.cochat.ai/papers/10.1001/archdermatol.2011.168
- The paper
- Guenova, E. (2011). Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With Ustekinumab. Archives of Dermatology. https://doi.org/10.1001/archdermatol.2011.168
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.